L. Mozo et al., Glucocorticoids inhibit IL-4 and mitogen-induced IL-4R alpha chain expression by different posttranscriptional mechanisms, J ALLERG CL, 102(6), 1998, pp. 968-976
Background: A high level of expression of IL-4R alpha chain on the surface
of lymphocytes has been described in certain allergic and inflammatory auto
immune diseases. Progression of these diseases are usually controlled by st
eroid treatment. One mechanism by which these drugs exert their antiinflamm
atory and immunosuppressive effects is by widely repressing or enhancing th
e production of cytokines and their receptors.
Objectives: The effect of glucocorticoids on IL-4R alpha chain expression h
as not been previously studied, and this is the aim of the present report.
For this purpose, human lymphocytes were induced to express IL-4R alpha cha
in by means of protein kinase C (PKC) activation with phorbol myristate ace
tate (PMA) or by triggering the Janus kinase-Stat pathway with IL-4 in the
presence or absence of pharmacologic doses of dexamethasone.
Methods: IL-4R alpha cell surface expression was studied by flow cytofluoro
metry. The levels and stability of mRNA were assessed by Northern blot anal
ysis. The effect of dexamethasone on the IL-4R alpha rate of transcription
was determined by nuclear run-on experiments.
Results: Dexamethasone significantly downregulated PMA-induced IL-4R alpha
mRNA and protein levels in total peripheral blood mononuclear cells and in
isolated T cells. The mechanism involved a posttranscriptional regulation o
f IL-4R alpha expression because dexamethasone decreased the PMA-induced IL
-4R alpha mRNA half-life. However, we found that PMA did not influence the
transcription rate of IL-4R alpha gene, irrespective of the presence or abs
ence of dexamethasone. This immunosuppressor also diminished the IL-4induce
d IL-4R alpha expression on the surface of isolated T and B lymphocytes but
, interestingly, without modifying mRNA levels that indicates that dexameth
asone downregulated IL-4-dependent IL-4R alpha expression by acting at a tr
anslational or posttranslational level. In fact, we observed that the drug
did not affect IL-4-induced IL-4R alpha gene transcription rate nor did it
shorten mRNA half-life. The effect of dexamethasone on the IL-4R alpha was
steroid specific because it was totally reversed by the glucocorticoid rece
ptor antagonist RU486.
Conclusion: Our results support that dexamethasone may influence the course
of allergic and inflammatory diseases by downregulating the expression of
IL-4R alpha.